Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-11

Clinical Trial Update: A Trial for New Treatment of Adult Participants With Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a new treatment in adults with Irritable Bowel Syndrome has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 4D pharma plc

Snippet

Sponsor: 4D pharma plc | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2022-01-11